...
首页> 外文期刊>PLoS One >Random forest model for feature-based Alzheimer’s disease conversion prediction from early mild cognitive impairment subjects
【24h】

Random forest model for feature-based Alzheimer’s disease conversion prediction from early mild cognitive impairment subjects

机译:从早期认知障碍受试者的基于特征的阿尔茨海默病的随机林模型

获取原文

摘要

Alzheimer’s Disease (AD) conversion prediction from the mild cognitive impairment (MCI) stage has been a difficult challenge. This study focuses on providing an individualized MCI to AD conversion prediction using a balanced random forest model that leverages clinical data. In order to do this, 383 Early Mild Cognitive Impairment (EMCI) patients were gathered from the Alzheimer’s Disease Neuroimaging Initiative (ADNI). Of these patients, 49 would eventually convert to AD (EMCI_C), whereas the remaining 334 did not convert (EMCI_NC). All of these patients were split randomly into training and testing data sets with 95 patients reserved for testing. Nine clinical features were selected, comprised of a mix of demographic, brain volume, and cognitive testing variables. Oversampling was then performed in order to balance the initially imbalanced classes prior to training the model with 1000 estimators. Our results showed that a random forest model was effective (93.6% accuracy) at predicting the conversion of EMCI patients to AD based on these clinical features. Additionally, we focus on explainability by assessing the importance of each clinical feature. Our model could impact the clinical environment as a tool to predict the conversion to AD from a prodromal stage or to identify ideal candidates for clinical trials.
机译:阿尔茨海默病的疾病(AD)来自轻度认知障碍(MCI)阶段的转换预测是一个艰难的挑战。本研究侧重于使用利用临床资料的平衡随机林模型为广告转换预测提供个性化MCI。为此,从阿尔茨海默氏病神经影像倡议(ADNI)收集了383名早期的轻度认知障碍(EMCI)患者。在这些患者中,49最终将转换为广告(EMCI_C),而剩余的334没有转换(EMCI_NC)。所有这些患者随机分裂到培训和测试数据集中,用95名患者预留进行测试。选择了九种临床特征,包括组合的人口统计学,脑体积和认知测试变量。然后执行过采样以便在使用1000估计器培训模型之前平衡最初不平衡的类。我们的研究结果表明,随机森林模型在预测基于这些临床特征的情况下,预测EMCI患者的转化为AD的转化率有效(93.6%)。此外,我们通过评估每个临床特征的重要性来专注于解释性。我们的模型可能会影响临床环境作为预测从前驱阶段转化为广告的工具,或识别临床试验的理想候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号